A systematic study of nuclear interactome of C-terminal domain small phosphatase-like 2 using inducible expression system and shotgun proteomics |
Kang, NaNa
(Department of Brain & Cognitive Sciences, DGIST)
Koo, JaeHyung (Department of Brain & Cognitive Sciences, DGIST) Wang, Sen (Qiqihar Medical University) Hur, Sun Jin (Department of Animal Science and Technology, Chung-Ang University) Bahk, Young Yil (Department of Biotechnology, Konkuk University) |
1 | Licciardo P, Amente S and Ruggiero L (2003) The FCP1 phosphatase interacts with RNA polymerase II and with MEP50 a component of the methylosome complex involved in the assembly of snRNP. Nucleic Acids Res 31, 999-1005 DOI |
2 | Bataille AR, Jeronimo C and Jacques PE (2012) A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase, and isomerase enzymes along genes. Mol Cell 45, 158-170 DOI |
3 | Chambers RS and Dahmus ME (1994) Purification and characterization of a phosphatase from HeLa cells, which dephosphorylates the C terminal domain of RNA polymerase II. J Biol Chem 269, 26243-26248 |
4 | Kemmer D, Podowki RM and Arenillas D (2006) Novel-Fam3000-uncharacterized human protein domains. BMC Genomics 7, 1471-2164 DOI |
5 | Hsin J-P and Manley JL (2012) The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev 26, 2119-2137 DOI |
6 | Zhao Y, Xiao M, Sun B et al (2014) C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via smad dephosphorylation. J Biol Chem 289, 26441-26450 |
7 | Harikrishna RR, Kim H, Noh K and Kim YJ (2014) Diverse roles in RNA polymerase II C-terminal domain phosphatase SCP1. BMB Rep 47, 192-196 DOI |
8 | Kamenski T, Heilmeier S, Meinhart A et al (2004) Structure and mechanism of RNA polymerase II CTD phosphatases. Mol Cell 15, 399-407 DOI |
9 | Ma YN, Zhang X, Yu HC and Zhang JW (2010) CTD small phosphatase like 2 (CTDSPL2) can increase ε- and γ-globin gene expression in K562 cells and CD34+ cells derived from umbilical cord blood. BMC Cell Biol 11, 75-86 DOI |
10 | Qian H, Ji C, Zhao S et al (2007) Expression and characterization of HSPC129, a RNA polymerase II C-terminal domain phosphatase. Mol Cell Biochem 303, 183-188 DOI |
11 | Alberts B (1998) The cell as a collection of protein machines: preparing the next generation of molecular biologists. Cell 92, 291-294 DOI |
12 | Koo JH and Bahk YY (2014) In vivo putative O-GlcNAcylation of human SCP1 and evidence for possible role of its N-terminal disorder structure. BMB Rep 47, 593-598 DOI |
13 | Blalock W, Piazzi M, Bavelloni A et al (2014) Identification of the PKR nuclear interactome reveals roles in ribosome biogenesis, mRNA processing and cell division. J Cell Physiol 229, 1047-1060 DOI |
14 | Bahk YY, Cho IH and Kim TS (2008) A cross-talk between oncogenic Ras and tumor suppressor PTEN through FAK Tyr861 phosphorylation in NIH/3T3 mouse embryonic fibroblasts. Biochem Biophys Res Comm 377, 1199-1204 DOI |
15 | Maehama T, Taylor GS, Slama JT and Dixon JE (2000) A sensitive assay for phosphoinositide phosphatases. Anal Biochem 279, 248-250 DOI |
16 | Kwon Y, Vinayagam A, Sun X et al (2013) The Hippo signaling pathway interactome. Science 342, 737-740 DOI |
17 | Bahk YY, Lee J, Cho IH and Lee HW (2010) An analysis of an interactome for apoptosis factor, Ei24/PIG8, using the inducible expression system and shotgun proteomics. J Proteome Res 9, 5270-5283 DOI |
18 | Kim S, Lee YZ and Bahk YY (2008) A proteomic approach for protein-profiling the oncogenic ras induced transformation (H-, K-, and N-Ras) in NIH/3T3 mouse embryonic fibroblasts. Proteomics 8, 3082-3093 DOI |
19 | Powers CA, Mathur M, Raaka BM, Ron D and Samuels HH (1998) TLS (translocated-in liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. Mol Endocrinol 12, 4-18 DOI |
20 | Kim YJ and Bahk YY (2014) A study of substrate specificity for a CTD phosphatase, SCP1, by proteomics screening of binding partners. Biochem Biophys Res Comm 448, 189-124 DOI |
21 | Zhao G, Shi L, Qiu D, Hu H and Kao PN (2005) NF45/ILF2 tissue expression, promoter analysis, and interleukin-2 transactivating function. Exp Cell Res 305, 312-323 DOI |
22 | Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133 DOI |
23 | Sun M, Yamashita T, Shang J et al (2014) Acceleration of TDP43 and FUS/TLS protein expressions in the preconditioned hippocampus following repeated transient ischemia. J Neurosci Res 92, 53-63 DOI |
24 | Perkins DN, Pappin DJ, Cressy DM and Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567 DOI |